#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Conjunctivitis allergic Vernal keratoconjunctivitis Thalassaemia alpha Hyperadrenocorticism Hepato-lenticular degeneration Ependymoma Superficial vein thrombosis Cardiac arrest Hodgkin's disease recurrent Undifferentiated sarcoma Heavy menstrual bleeding Brain abscess Pancreatic carcinoma metastatic Systemic lupus erythematosus Inflammatory myofibroblastic tumour More trials…

    Learn about Rare Diseases

    Breast angiosarcoma – Treatment Lennox-Gastaut syndrome – Basic Information Hairy cell leukaemia recurrent SAPHO syndrome Pituitary-dependent Cushing’s syndrome – Treatment Prolymphocytic leukaemia – Treatment Richter’s syndrome – Life with Disease Medulloblastoma recurrent Marfan’s syndrome – Treatment Hereditary angioedema More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sacituzumab Govitecan Soya-Bean Oil Refined Izaflortaucipir (18F) Relatlimab Tioguanine Citric Acid Monohydrate Levomethadone Hydrochloride Onfekafusp Alfa Peppermint Oil Gs-1427 Osimertinib Dazukibart CANNABINOL Morphine Sulfate Cytarabine Nebivolol Cabergoline Ecoo15 Bgb-A445 For-6219 More therapies…

    Learn about Your Condition

    Alcohol use disorder Epilepsy Pyelonephritis acute Oesophageal disorder Atrial flutter Post procedural oedema Heart disease congenital Diabetic autonomic neuropathy Viral myocarditis Growth hormone deficiency Neoplasm malignant Infantile spasms Nephrolithiasis Venous thrombosis Post procedural swelling More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Rabies Prophylaxis in Healthy Volunteers After Rabies Virus (Inactivated) Strain Flury LEP Vaccination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rabies
    Belgium

  • Maribavir for High Epstein-Barr Virus Infection in Young Adult Kidney Transplant Recipients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    Investigated Drugs:
    • Maribavir
    Spain

  • Evaluating measles, mumps, rubella vaccine (live) in lactating women to enhance infant mucosal immunity

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Mumps Virus Jeryl Lynn (Level B) Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Rubella Virus Wistar Ra 27/3 Strain (Live, Attenuated) Produced In Wi-38 Human Diploid Lung Fibroblasts
    Belgium

  • Using fludeoxyglucose (18F) in PET/CT imaging to diagnose and monitor cardiovascular device infections

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Device related infection
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    Spain

  • A study to evaluate the safety and effectiveness of MRNA3771 and GRNA1599 in adults with chronic hepatitis B

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • GRNA1599
    France

  • A study to evaluate the effectiveness of upadacitinib and pirfenidone in reducing symptom severity in patients with Long Covid

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Pirfenidone
    • Cellulose, Microcrystalline
    • Upadacitinib
    Italy
Previous Page
1 … 15 16 17 18 19 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!